Loading
₹1,570.00
−26.80−1.68%today
Market closed · 7 Oct, 3:30 pm
+149.92%over 1 year
Today's range
₹1,553.70₹1,596.80
52-week range
₹570.75₹1,899.00
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 1,731 | 247 | 14.3% | 15.31 |
| FY25 | 1,267 | n/a | n/a | n/a |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Promoters | 59.76% | 59.86% | 59.99% |
| FIIs | 7.52% | 7.54% | 7.99% |
| DIIs | 9.43% | 10.02% | 9.45% |
| of which mutual funds | 7.23% | 7.14% | 6.61% |
| Government | 0.00% | 0.00% | 0.00% |
| Public | 23.30% | 22.58% | 22.57% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Dr. Lal Path Labs Ltd.LALPATHLAB | 1,938.00 | −1.33% | 32,529 |
| Krishna Institute of Medical Sciences Ltd.KIMS | 693.00 | −0.06% | 29,106 |
| Neuland Laboratories Ltd.NEULANDLAB | 21,610.00 | −1.35% | 27,725 |
| Piramal Pharma Ltd.PPLPHARMA | 202.67 | +1.07% | 26,982 |
| Rubicon Research Ltd.RUBICON · this stock | 1,570.00 | −1.68% | 25,989 |
| Acutaas Chemicals Ltd.ACUTAAS | 3,168.60 | +0.38% | 25,942 |
| Granules India Ltd.GRANULES | 845.80 | +1.12% | 20,959 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.